Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 2004 - 2007
- University of California (San Francisco)Residency, Obstetrics and Gynecology, 1999 - 2002
- Harvard Medical SchoolClass of 1999
Certifications & Licensure
- CA State Medical License 2001 - 2026
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 111 citationsPhase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosingDanny Rischin, Michael R. Migden, Annette M. Lim, Chrysalyne D. Schmults, Nikhil I. Khushalani
Journal for Immunotherapy of Cancer. 2020-06-01 - 57 citationsIntegrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults, Alexander Guminski, Anne Lynn S. Chang
Journal for Immunotherapy of Cancer. 2021-08-01 - 10 citationsAn exploratory, open-label, investigator-initiated study of interleukin-17 blockade in patients with moderate-to-severe papulopustular rosacea.Anusha Kumar, A.S. Chiou, Yi Hsien Shih, Shufeng Li, Anne Lynn S. Chang
The British Journal of Dermatology. 2020-05-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: